Literature DB >> 10762270

Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the Staphylococcal peptidoglycan interpeptide bridge.

K Ehlert1, M Tschierske, C Mori, W Schröder, B Berger-Bächi.   

Abstract

The FemAB-like factors Lif and Epr confer resistance to glycylglycine endopeptidases lysostaphin and Ale-1, respectively, by incorporating serine residues into the staphylococcal peptidoglycan interpeptide bridges specifically at positions 3 and 5. This required the presence of FemA and/or FemB, in contrast to earlier postulations.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10762270      PMCID： PMC111332          DOI： 10.1128/JB.182.9.2635-2638.2000

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  11 in total

1.  Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation.

Authors:  M Tschierske; K Ehlert; A M Strandén; B Berger-Bächi
Journal:  FEMS Microbiol Lett       Date:  1997-08-15       Impact factor: 2.742

2.  epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.

Authors:  M Sugai; T Fujiwara; K Ohta; H Komatsuzawa; M Ohara; H Suginaka
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.

Authors:  J M Robinson; J K Hardman; G L Sloan
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

4.  The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation.

Authors:  S Rohrer; K Ehlert; M Tschierske; H Labischinski; B Berger-Bächi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

5.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03

6.  Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target?

Authors:  U Kopp; M Roos; J Wecke; H Labischinski
Journal:  Microb Drug Resist       Date:  1996       Impact factor: 3.431

7.  Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus.

Authors:  A M Strandén; K Ehlert; H Labischinski; B Berger-Bächi
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

8.  Specificities of FemA and FemB for different glycine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pentaglycine side chain formation.

Authors:  K Ehlert; W Schröder; H Labischinski
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

9.  Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus.

Authors:  U Henze; T Sidow; J Wecke; H Labischinski; B Berger-Bächi
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

10.  The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.

Authors:  H P DeHart; H E Heath; L S Heath; P A LeBlanc; G L Sloan
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792
View more
  18 in total

Review 1.  FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci.

Authors:  S Rohrer; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 2.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

3.  Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.

Authors:  Jennifer L Koehl; Arunachalam Muthaiyan; Radheshyam K Jayaswal; Kerstin Ehlert; Harald Labischinski; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 4.  Roles of tRNA in cell wall biosynthesis.

Authors:  Kiley Dare; Michael Ibba
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-01-19       Impact factor: 9.957

Review 5.  Bacterial transfer RNAs.

Authors:  Jennifer Shepherd; Michael Ibba
Journal:  FEMS Microbiol Rev       Date:  2015-03-21       Impact factor: 16.408

6.  Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.

Authors:  M W Climo; K Ehlert; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 7.  Direction of aminoacylated transfer RNAs into antibiotic synthesis and peptidoglycan-mediated antibiotic resistance.

Authors:  Jennifer Shepherd; Michael Ibba
Journal:  FEBS Lett       Date:  2013-07-29       Impact factor: 4.124

8.  Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.

Authors:  Nandini Kiri; Gordon Archer; Michael W Climo
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

9.  Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo.

Authors:  Caroline Kusuma; Anna Jadanova; Tanya Chanturiya; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

10.  FmhA and FmhC of Staphylococcus aureus incorporate serine residues into peptidoglycan cross-bridges.

Authors:  Stephanie Willing; Emma Dyer; Olaf Schneewind; Dominique Missiakas
Journal:  J Biol Chem       Date:  2020-08-05       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.